Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of rupatadine fumarate nanoemulsion and its preparation method and application

A technology of rupatadine fumarate and nanoemulsion, which is applied in the field of medicine and can solve problems such as tooth damage in children

Active Publication Date: 2022-07-26
北京华氏开元医药科技有限公司
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the above two preparations contain cyclodextrin compounds, long-term use of drugs containing cyclodextrin compounds will cause damage to children's teeth

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of rupatadine fumarate nanoemulsion and its preparation method and application
  • A kind of rupatadine fumarate nanoemulsion and its preparation method and application
  • A kind of rupatadine fumarate nanoemulsion and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0049] In a second aspect, an embodiment of the present invention provides a method for preparing a rupatadine fumarate nanoemulsion according to the first aspect, comprising the following steps:

[0050] Weigh the cosurfactant and rupatadine fumarate in the formula amount, and mix them evenly to obtain the first mixture;

[0051] Weigh the surfactant and the oil phase of the formula, and mix them uniformly to obtain the second mixture;

[0052] The first mixture is added to the second mixture, mixed uniformly, and water is added dropwise while stirring, until a stable clear emulsion is formed;

[0053] A pH adjuster is added to the stable and clear emulsion, the pH is adjusted to 5-6, and water is added to make up the volume to obtain a rupatadine fumarate nanoemulsion.

[0054] The preparation method of the rupatadine fumarate nanoemulsion provided by the invention can maximize the drug loading by mixing in stages, the method is simple, reliable, and has good repeatability,...

Embodiment 1

[0062] The components of the rupatadine fumarate nanoemulsion provided in this example are shown in Table 1.

[0063] The preparation method of the rupatadine fumarate nanoemulsion provided in this embodiment is:

[0064] (1) weigh 10g of propylene glycol and 128mg of rupatadine fumarate, mix and stir to obtain a first mixture;

[0065] (2) take by weighing 15g Tween 80, 5g Span 80 and 50g ethyl oleate, mix and stir to obtain the second mixture;

[0066] (3) the first mixture is added to the second mixture, mixed and stirred, and distilled water is added dropwise while stirring, until a stable clear and transparent emulsion is formed;

[0067] (4) Add 0.397g of citric acid and 0.568g of disodium hydrogen phosphate to the above stable, clear and transparent emulsion, adjust the pH to 5.2, add distilled water to dilute to 100mL, and filter to obtain rupatadine fumarate nanoemulsion.

Embodiment 2

[0069] The components of the rupatadine fumarate nanoemulsion provided in this example are shown in Table 1.

[0070] The preparation method of the rupatadine fumarate nanoemulsion provided in this embodiment is:

[0071] (1) weigh 10g of propylene glycol and 128mg of rupatadine fumarate, mix and stir to obtain a first mixture;

[0072] (2) take by weighing 20g Tween 80, 5g Span 80 and 45g ethyl oleate, mix and stir to obtain the second mixture;

[0073] (3) the first mixture is added to the second mixture, mixed and stirred, and distilled water is added dropwise while stirring, until a stable clear and transparent emulsion is formed;

[0074] (4) Add 0.320g of citric acid and 0.568g of disodium hydrogen phosphate to the above stable, clear and transparent emulsion, adjust the pH to 5.5, add distilled water to dilute to 100mL, and filter to obtain rupatadine fumarate nanoemulsion.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
polydispersity indexaaaaaaaaaa
Login to View More

Abstract

The invention belongs to the field of medicine, and in particular relates to a rupatadine fumarate nanoemulsion and a preparation method and application thereof. Each 100ml of rupatadine fumarate nanoemulsion includes the following components: rupatadine fumarate 100mg~150mg; oil phase 40g~60g; surfactant 10g~30g; cosurfactant 5g~15g; pH An appropriate amount of regulator; water to 100mL. The nanoemulsion provided by the invention does not contain cyclodextrin compounds, has higher safety, uniform particle size distribution, clear and transparent appearance, good fluidity and stability, and can increase the solubility of rupatadine fumarate and increase the bioavailability.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to a rupatadine fumarate nanoemulsion and a preparation method and application thereof. Background technique [0002] Rupatadine fumarate, chemical name is 8-chloro-6,11-dihydro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidinylidene] -5H-benzo[5,6]cycloheptano[1,2-b]pyridine fumarate. Rupatadine fumarate is a new and potent anti-allergic drug developed by Spain's Uriach Pharmaceutical Company, which is a selective histamine H1 receptor inverse agonist and a platelet activating factor (PAF) antagonist. In animal experiments, this product shows strong histamine H1 receptor antagonistic effect and PAF receptor blocking effect; it has inhibitory effect on mast cell degranulation, neutrophil and eosinophil migration and cytokine release . This product was first marketed in Spain on March 15, 2003. Compared with loratadine and cetirizine, this product has better efficacy and less si...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/107A61K31/4545A61K47/14A61K47/10A61P37/08A61P11/02
CPCA61K9/1075A61K31/4545A61K47/14A61K47/10A61P37/08A61P11/02
Inventor 马燕辉潘海群侯培宁侯宇翔戴信敏
Owner 北京华氏开元医药科技有限公司